Sionna Therapeutics, Inc./$SION
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Sionna Therapeutics, Inc.
Sionna Therapeutics Inc is a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis (CF) patients by developing novel medicines that normalize the function of the cystic fibrosis transmembrane conductance regulator (CFTR) protein to deliver clinically meaningful benefits to CF patients. CF is a progressive and life-threatening genetic disease caused by inherited mutations in the CFTR gene, which heads to insufficient CFTR function. The Company is managed as one operating segment focused on the research and development of cystic fibrosis therapies.
Ticker
$SION
Sector
Primary listing
Employees
59
Headquarters
Website
SION Metrics
BasicAdvanced
$1.7bn
-
-$1.92
-
-
Price and volume
Market cap
$1.7bn
52-week high
$48.45
52-week low
$13.81
Average daily volume
397k
Financial strength
Current ratio
22.602
Quick ratio
22.11
Long term debt to equity
2.448
Total debt to equity
2.907
Profitability
EBITDA (TTM)
-98.28
Management effectiveness
Return on assets (TTM)
-18.33%
Return on equity (TTM)
-26.74%
Valuation
Price to book
5.83
Price to tangible book (TTM)
5.83
Price to free cash flow (TTM)
-23.031
Free cash flow yield (TTM)
-4.34%
Free cash flow per share (TTM)
-1.62
Growth
Earnings per share change (TTM)
-71.80%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs